NQO1 rs1800566 C>T polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 3, 2014, Pages 317-322

  Yin, Jun ^a   Wang, Liming ^a   Wang, Xu ^a   Zheng, Liang ^b   Shi, Yijun ^a   Shao, Aizhong ^a   Tang, Weifeng ^a   Ding, Guowen ^a   Liu, Chao ^a   Liu, Ruiping ^c   Chen, Suocheng ^a   Gu, Haiyong ^a  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal cancer; Molecular epidemiology; NQO1; NQO2; Polymorphisms

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPING TECHNIQUES; HOMOZYGOTE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NAD(P)H DEHYDROGENASE (QUINONE); ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84894203868     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.873819     Document Type: Article

References (16)

1. Chen W, He Y, Zheng R, Zhang S, Zeng H, Zou X, et al. Esophageal cancer incidence and mortality in china, 2009. J Thorac Dis 2013;5:19-26.
2. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, Arnason S, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004;1:e65.
3. Joseph P, Jaiswal AK. NAD (P) H: Quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci USA 1994;91:8413-17.
4. Asher G, Lotem J, Cohen B, Sachs L, Shaul Y. Regulation of p53 stability and p53-dependent apoptosis by nadh quinone oxidoreductase 1. Proc Natl Acad Sci USA 2001;98:1188-93.
5. Siegel D, Ross D. Immunodetection of NAD (P) H: quinone oxidoreductase 1 (NQO1) in human tissues. Free Radic Biol Med 2000;29:246-53.
6. Cresteil T, Jaiswal AK. High levels of expression of the NAD (P) H: quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol 1991;42:1021-7.
7. Danson S, Ward TH, Butler J, Ranson M. DT-diaphorase: a target for new anticancer drugs. Cancer Treat Rev 2004;30:437-49.
8. Siegel D, McGuinness SM, Winski SL, Ross D. Genotypephenotype relationships in studies of a polymorphism in NAD (P) H: quinone oxidoreductase 1. Pharmacogenetics 1999;9:113-21.
9. Sameer AS, Shah ZA, Syeed N, Rasool R, Afroze D, Siddiqi MA. NAD (P) H: Quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic kashmiri population. Asian Pac J Cancer Prev 2010;11:209-13.
10. Yanling H, Yuhong Z, Wenwu H, Lei X, Mingwu C. NQO1 C609T polymorphism and esophageal cancer risk: a huge review and meta-analysis. BMC Med Genet 2013;14:31.
11. Iida A, Sekine A, Saito S, Kitamura Y, Kitamoto T, Osawa S, et al. Catalog of 320 single nucleotide polymorphisms (SNPs) in 20 quinone oxidoreductase and sulfotransferase genes. J Hum Genet 2001;46:225-40.
12. Harada S, Fujii C, Hayashi A, Ohkoshi N. An association between idiopathic parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione s-transferase m1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 2001;288:887-92.
13. Yuan W, Xu L, Chen W, Wang L, Fu Z, Pang D, et al. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis. Breast Cancer Res Treat 2011;125:467-72.
14. Lajin B, Alachkar A. The NQO1 polymorphism C609t (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis. Br J Cancer 2013;109:1325-37.
15. De Aguiar Goncalves BA, Vasconcelos GM, Thuler LC, Andrade C, Faro A, Pombo-de-Oliveira MS, et al. NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (l55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution. Cancer Causes Control 2012;23:1811-19.
16. Gaikwad NW, Rogan EG, Cavalieri EL. Evidence from esims for nqo1-catalyzed reduction of estrogen ortho-quinones. Free Radic Biol Med 2007;43:1289-98.